CONTRACT FOR THE MANUFACTURING OF PHARMACEUTICAL PRODUCTSManufacturing Agreement • November 15th, 2016 • Immune Therapeutics, Inc. • Pharmaceutical preparations
Immune Therapeutics, Inc. registered under the laws of the State of Florida, United States of America, and incorporated under P3000082736Twrth its corporate domicile and main office at 37 N Orange Ave 607, Orlando Florida and represented by Noreen Griffin, Chief Executive Officer, with her Passport No.496803653.
EXCLUSIVE AGENCY AGREEMENTExclusive Agency Agreement • November 15th, 2016 • Immune Therapeutics, Inc. • Pharmaceutical preparations • Florida
This EXCLUSIVE AGENCY AGREEMENT is made and entered into this 31st day of October, 2016 by and among Immune Therapeutics, Inc., a Florida corporation (“IMUN”), its wholly owned subsidiary, TNI BioTech International, Ltd., a BVI company (collectively with IMUN, the “Company”), and GB Pharma Holdings, LLC, a Delaware limited liability company (“Agent”). The Company and Agent are each referred to herein as a “Party” and collectively as the “Parties.”
